Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.37 USD | +2.29% | +2.45% | -30.30% |
Jun. 05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.30% | 140M | |
+46.93% | 56.87B | |
+37.74% | 39.72B | |
-6.13% | 39.27B | |
-6.90% | 28.73B | |
+14.01% | 26.21B | |
-16.57% | 19.79B | |
+32.73% | 12.28B | |
+28.07% | 12.23B | |
+0.16% | 12.12B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024